Data and analytics developers Health Catalyst is set to acquire Twistle, a company that automates patient-centered, HIPAA-compliant communication between care teams and patients.

The two expect the combination of their technologies to create a comprehensive go-to-market solution that can address population health needs within healthcare organizations and assist life science facilities worldwide.

“Health Catalyst's patient insights can trigger personalized outreach, and the patient's unique profile will allow Twistle's communication pathways to adapt to their preferences and attributes in unprecedented ways. We are excited about the prospects of our joint solutions proactively engaging at-risk populations, advancing health equity, and improving patient activation in their care," said Kulmeet Singh, founder and CEO of Twistle, in a statement.

The deal will focus on pairing Twistle’s clinical workflow and patient engagement platform with Health Catalyst’s population health offering.

A healthcare patient engagement SaaS technology company, Health Catalyst has designed a cloud-based data platform, DOS, that can collect data-driven patient interactions. This information is expected to enhance the automation of Twistle’s technology, which in turn will enhance the use of Health Catalyst’s clinical, quality, and Life Sciences solutions, through established clinical pathways and patient communication channels.

The result is expected to be a better patient experience, with better outcomes and reduced costs, according to Health Catalyst CEO Dan Burton. “Twistle is a leading healthcare technology company committed to developing software that healthcare organizations and Life Science companies need to keep patients engaged in their healthcare. Their efforts to improve patient outcomes and reduce the cost of care are deeply aligned with our mission to be the catalyst for massive, measurable, data-informed improvements.”

Health Catalyst plans to use a mix of stock and cash to complete the transaction.

Both expect it to close in early Q3 2021. The agreement will be subject to customary closing conditions.

Business Affairs Homepage